{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:26:49Z","timestamp":1788456409172,"version":"build-2803163510"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Non-suicidal self-injury (NSSI) in adolescents has previously been linked to alterations in the endocannabinoid system. While increasing evidence supports endocannabinoid levels as potential biomarker in psychiatric care, little is known about their longitudinal trajectories over the course of treatment or in predicting clinical symptoms. This is the first study to investigate endocannabinoids in a longitudinal cohort of patients with NSSI, exploring associations with the development of symptoms over time. Plasma endocannabinoids and NSSI, using the German version of the\n                    <jats:italic>Self-Injurious Thoughts and Behaviors Interview<\/jats:italic>\n                    (SITBI-G), were assessed in\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200947 female adolescents with NSSI at both baseline and after one year of treatment (follow-up). Associations between endocannabinoid levels and clinical symptoms over time were analyzed. Anandamide (AEA) significantly decreased from baseline to follow-up while 2-arachidonoylglycerol (2-AG) increased after one year. While lower AEA levels have previously been reported in adolescents with NSSI, this longitudinal study found that AEA decreased over one year despite an overall improvement in NSSI symptoms. The overall pattern suggests that changes in circulating endocannabinoids do not closely correspond to symptom improvement. These findings indicate that circulating endocannabinoid levels change over time in adolescents with NSSI, but their complex and partly inconsistent associations with clinical symptoms limit their clinical utility as biomarkers.\n                  <\/jats:p>","DOI":"10.1038\/s41398-026-04391-x","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:53:15Z","timestamp":1788447195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal changes in endocannabinoids and clinical course of adolescent non-suicidal self-injury"],"prefix":"10.1038","volume":"16","author":[{"given":"Marc D.","family":"Ferger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5631-0663","authenticated-orcid":false,"given":"Susanne","family":"Brodesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0031-7764","authenticated-orcid":false,"given":"Michael","family":"Kaess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1009-9625","authenticated-orcid":false,"given":"Julian","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"4391_CR1","unstructured":"International Society for the Study of Self-injury. What is self-injury? Httpsitriplesorgabout-Self-Inj--Self-Inj 2018.https:\/\/itriples.org\/about-self-injury\/what-is-self-injury. Accessed 2 September 2026."},{"key":"4391_CR2","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jad.2023.07.091","volume":"339","author":"L De Luca","year":"2023","unstructured":"De Luca L, Pastore M, Palladino BE, Reime B, Warth P, Menesini E. The development of non-suicidal self-injury (NSSI) during adolescence: a systematic review and Bayesian meta-analysis. J Affect Disord. 2023;339:648\u201359.","journal-title":"J Affect Disord"},{"key":"4391_CR3","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1001\/jamapsychiatry.2022.1256","volume":"79","author":"RT Liu","year":"2022","unstructured":"Liu RT, Walsh RFL, Sheehan AE, Cheek SM, Sanzari CM. Prevalence and correlates of suicide and nonsuicidal self-injury in children: a systematic review and meta-analysis. JAMA Psychiatry. 2022;79:718\u201326.","journal-title":"JAMA Psychiatry"},{"key":"4391_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cpr.2015.02.009","volume":"38","author":"K Bresin","year":"2015","unstructured":"Bresin K, Schoenleber M. Gender differences in the prevalence of nonsuicidal self-injury: a meta-analysis. Clin Psychol Rev. 2015;38:55\u201364.","journal-title":"Clin Psychol Rev"},{"key":"4391_CR5","doi-asserted-by":"publisher","first-page":"e2415436","DOI":"10.1001\/jamanetworkopen.2024.15436","volume":"7","author":"F Moloney","year":"2024","unstructured":"Moloney F, Amini J, Sinyor M, Schaffer A, Lanct\u00f4t KL, Mitchell RHB. Sex differences in the global prevalence of nonsuicidal self-injury in adolescents: a meta-analysis. JAMA Netw Open. 2024;7:e2415436.","journal-title":"JAMA Netw Open"},{"key":"4391_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-023-04800-1","volume":"23","author":"Y Chen","year":"2023","unstructured":"Chen Y, Fu W, Ji S, Zhang W, Sun L, Yang T, et al. Relationship between borderline personality features, emotion regulation, and non-suicidal self-injury in depressed adolescents: a cross-sectional study. BMC Psychiatry. 2023;23:293.","journal-title":"BMC Psychiatry"},{"key":"4391_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/NDT.S443454","volume":"20","author":"S Niu","year":"2024","unstructured":"Niu S, Yin X, Pan B, Chen H, Dai C, Tong C, et al. Understanding comorbidity between non-suicidal self-injury and depressive symptoms in a clinical sample of adolescents: a network analysis. Neuropsychiatr Dis Treat. 2024;20:1\u201317.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"4391_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.copsyc.2020.12.007","volume":"37","author":"C Reichl","year":"2021","unstructured":"Reichl C, Kaess M. Self-harm in the context of borderline personality disorder. Curr Opin Psychol. 2021;37:139\u201344.","journal-title":"Curr Opin Psychol"},{"key":"4391_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-024-05533-5","volume":"24","author":"E Seong","year":"2024","unstructured":"Seong E, Lee KH, Lee J-S, Kim S, Seo DG, Yoo JH, et al. Depression and posttraumatic stress disorder in adolescents with nonsuicidal self-injury: comparisons of the psychological correlates and suicidal presentations across diagnostic subgroups. BMC Psychiatry. 2024;24:138.","journal-title":"BMC Psychiatry"},{"key":"4391_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jad.2024.07.105","volume":"363","author":"BJ Turner","year":"2024","unstructured":"Turner BJ, Porter AC, Robillard CL. Average ages of onset and time to transition between self-injurious thoughts and behaviors: Retrospective evidence from two developmentally distinct samples. J Affect Disord. 2024;363:465\u201373.","journal-title":"J Affect Disord"},{"key":"4391_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101350","volume":"46","author":"Y-J Wang","year":"2022","unstructured":"Wang Y-J, Li X, Ng CH, Xu D-W, Hu S, Yuan T-F. Risk factors for non-suicidal self-injury (NSSI) in adolescents: a meta-analysis. eClinicalMedicine. 2022;46:101350.","journal-title":"eClinicalMedicine"},{"key":"4391_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.euroneuro.2022.02.009","volume":"58","author":"N Calvo","year":"2022","unstructured":"Calvo N, Garc\u00eda-Gonz\u00e1lez S, Perez-Galbarro C, Regales-Peco C, Lugo-Marin J, Ramos-Quiroga J-A, et al. Psychotherapeutic interventions specifically developed for NSSI in adolescence: a systematic review. Eur Neuropsychopharmacol. 2022;58:86\u201398.","journal-title":"Eur Neuropsychopharmacol"},{"key":"4391_CR13","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00787-019-01399-1","volume":"29","author":"M Kaess","year":"2020","unstructured":"Kaess M, Edinger A, Fischer-Waldschmidt G, Parzer P, Brunner R, Resch F. Effectiveness of a brief psychotherapeutic intervention compared with treatment as usual for adolescent nonsuicidal self-injury: a single-centre, randomised controlled trial. Eur Child Adolesc Psychiatry. 2020;29:881\u201391.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"4391_CR14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1177\/070674371405901103","volume":"59","author":"BJ Turner","year":"2014","unstructured":"Turner BJ, Austin SB, Chapman AL. Treating nonsuicidal self-injury: a systematic review of psychological and pharmacological interventions. Can J Psychiatry. 2014;59:576\u201385.","journal-title":"Can J Psychiatry"},{"key":"4391_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-017-0767-9","volume":"19","author":"RC Brown","year":"2017","unstructured":"Brown RC, Plener PL. Non-suicidal self-injury in adolescence. Curr Psychiatry Rep. 2017;19:20.","journal-title":"Curr Psychiatry Rep"},{"key":"4391_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-025-06735-1","volume":"25","author":"X Chen","year":"2025","unstructured":"Chen X, Dong Y, Ye M, Wang X, Yan J, Yao Y, et al. Comparative efficacy and acceptability of psychotherapeutic, pharmacological, and combination treatments for non-suicidal self-injury in children and adolescents: a systematic review and network meta-analysis. BMC Psychiatry. 2025;25:328.","journal-title":"BMC Psychiatry"},{"key":"4391_CR17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrn4036","volume":"16","author":"B Lutz","year":"2015","unstructured":"Lutz B, Marsicano G, Maldonado R, Hillard CJ. The endocannabinoid system in guarding against fear, anxiety and stress. Nat Rev Neurosci. 2015;16:705\u201318.","journal-title":"Nat Rev Neurosci"},{"key":"4391_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41386-022-01438-7","volume":"48","author":"A Scheyer","year":"2023","unstructured":"Scheyer A, Yasmin F, Naskar S, Patel S. Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment. Neuropsychopharmacol. 2023;48:37\u201353.","journal-title":"Neuropsychopharmacol"},{"key":"4391_CR19","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/s41583-025-00961-y","volume":"26","author":"N Loomba","year":"2025","unstructured":"Loomba N, Patel S. Circuit mechanisms governing endocannabinoid modulation of affective behaviour and stress adaptation. Nat Rev Neurosci. 2025;26:677\u201397.","journal-title":"Nat Rev Neurosci"},{"key":"4391_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/npp.2017.206","volume":"43","author":"A Busquets-Garcia","year":"2018","unstructured":"Busquets-Garcia A, Bains J, Marsicano G. CB1 Receptor signaling in the brain: extracting specificity from ubiquity. Neuropsychopharmacol. 2018;43:4\u201320.","journal-title":"Neuropsychopharmacol"},{"key":"4391_CR21","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1152\/jn.00603.2006","volume":"97","author":"EL Hill","year":"2007","unstructured":"Hill EL, Gallopin T, F\u00e9r\u00e9zou I, Cauli B, Rossier J, Schweitzer P, et al. Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. J Neurophysiol. 2007;97:2580\u20139.","journal-title":"J Neurophysiol"},{"key":"4391_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/npp.2017.130","volume":"43","author":"CJ Hillard","year":"2018","unstructured":"Hillard CJ. Circulating endocannabinoids: from whence do they come and where are they going? Neuropsychopharmacology. 2018;43:155\u201372.","journal-title":"Neuropsychopharmacology"},{"key":"4391_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/npp.2015.166","volume":"41","author":"M Morena","year":"2016","unstructured":"Morena M, Patel S, Bains JS, Hill MN. Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2016;41:80\u2013102.","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"4391_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108626","volume":"195","author":"GN Petrie","year":"2021","unstructured":"Petrie GN, Nastase AS, Aukema RJ, Hill MN. Endocannabinoids, cannabinoids and the regulation of anxiety. Neuropharmacology. 2021;195:108626.","journal-title":"Neuropharmacology"},{"key":"4391_CR25","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1038\/s41386-022-01320-6","volume":"47","author":"S Weisser","year":"2022","unstructured":"Weisser S, Mueller M, Rauh J, Esser R, Fuss J, Lutz B, et al. Acquisition of threat responses are associated with elevated plasma concentration of endocannabinoids in male humans. Neuropsychopharmacol. 2022;47:1931\u20138. https:\/\/doi.org\/10.1038\/s41386-022-01320-6","journal-title":"Neuropsychopharmacol"},{"key":"4391_CR26","first-page":"S00928674240121","volume":"188","author":"SL Lesuis","year":"2024","unstructured":"Lesuis SL, Park S, Hoorn A, Rashid AJ, Mocle AJ, Salter EW, et al. Stress disrupts engram ensembles in lateral amygdala to generalize threat memory in mice. Cell. 2024;188:S0092867424012169.","journal-title":"Cell"},{"key":"4391_CR27","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1111\/bph.16198","volume":"180","author":"GN Petrie","year":"2023","unstructured":"Petrie GN, Balsevich G, F\u00fczesi T, Aukema RJ, Driever WPF, Van Der Stelt M, et al. Disruption of tonic endocannabinoid signalling triggers cellular, behavioural and neuroendocrine responses consistent with a stress response. Br J Pharmacol. 2023;180:3146\u201359.","journal-title":"Br J Pharmacol"},{"key":"4391_CR28","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1523\/JNEUROSCI.2737-14.2015","volume":"35","author":"JM Gray","year":"2015","unstructured":"Gray JM, Vecchiarelli HA, Morena M, Lee TTY, Hermanson DJ, Kim AB, et al. Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety. J Neurosci Off J Soc Neurosci. 2015;35:3879\u201392.","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"4391_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.psyneuen.2016.01.004","volume":"66","author":"JM Gray","year":"2016","unstructured":"Gray JM, Wilson CD, Lee TTY, Pittman QJ, Deussing JM, Hillard CJ, et al. Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function. Psychoneuroendocrinology. 2016;66:151\u20138.","journal-title":"Psychoneuroendocrinology"},{"key":"4391_CR30","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.psyneuen.2010.03.005","volume":"35","author":"MN Hill","year":"2010","unstructured":"Hill MN, Karatsoreos IN, Hillard CJ, McEwen BS. Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo. Psychoneuroendocrinology. 2010;35:1333\u20138.","journal-title":"Psychoneuroendocrinology"},{"key":"4391_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/j.2040-4603.2017.tb00740.x","volume":"7","author":"CJ Hillard","year":"2016","unstructured":"Hillard CJ, Beatka M, Sarvaideo J. Endocannabinoid signaling and the hypothalamic-pituitary-adrenal axis. Compr Physiol. 2016;7:1\u201315.","journal-title":"Compr Physiol"},{"key":"4391_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02628-7","volume":"13","author":"SL Kroll","year":"2023","unstructured":"Kroll SL, Hulka LM, Kexel A-K, Vonmoos M, Preller KH, Treyer V, et al. Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density. Transl Psychiatry. 2023;13:325.","journal-title":"Transl Psychiatry"},{"key":"4391_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03151-z","volume":"14","author":"R Mazurka","year":"2024","unstructured":"Mazurka R, Harkness KL, Hassel S, Stensson N, Nogovitsyn N, Poppenk J, et al. Endocannabinoid concentrations in major depression: effects of childhood maltreatment and relation to hippocampal volume. Transl Psychiatry. 2024;14:431.","journal-title":"Transl Psychiatry"},{"key":"4391_CR34","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jamapsychiatry.2019.0970","volume":"76","author":"A Minichino","year":"2019","unstructured":"Minichino A, Senior M, Brondino N, Zhang SH, Godwlewska BR, Burnet PWJ, et al. Measuring disturbance of the endocannabinoid system in psychosis: a systematic review and meta-analysis. JAMA Psychiatry. 2019;76:914\u201323.","journal-title":"JAMA Psychiatry"},{"key":"4391_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03205-2","volume":"14","author":"MD Ferger","year":"2024","unstructured":"Ferger MD, Sigrist C, Brodesser S, Kaess M, Koenig J. Alterations of the endocannabinoid system in adolescents with non-suicidal self-injury as a function of childhood maltreatment. Transl Psychiatry. 2024;14:491.","journal-title":"Transl Psychiatry"},{"key":"4391_CR36","doi-asserted-by":"publisher","first-page":"404","DOI":"10.13109\/prkk.2017.66.6.404","volume":"66","author":"M Kaess","year":"2017","unstructured":"Kaess M, Ghinea D, Fischer-Waldschmidt G, Resch F. Die ambulanz f\u00fcr risikoverhalten und selbstsch\u00e4digung (AtR!Sk) \u2013 ein pionierkonzept der ambulanten fr\u00fcherkennung und fr\u00fchintervention von borderline-pers\u00f6nlichkeitsst\u00f6rungen. Prax Kinderpsychol Kinderpsychiatr. 2017;66:404\u201322.","journal-title":"Prax Kinderpsychol Kinderpsychiatr"},{"key":"4391_CR37","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. Arlington, VA: American Psychiatric Association; 2013.","edition":"Fifth Edition"},{"key":"4391_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-50426-4","volume":"13","author":"K Amir Hamzah","year":"2023","unstructured":"Amir Hamzah K, Toms L-M, Kucharski N, Orr J, Turner NP, Hobson P, et al. Sex-dimorphism in human serum endocannabinoid and n-acyl ethanolamine concentrations across the lifespan. Sci Rep. 2023;13:23059.","journal-title":"Sci Rep"},{"key":"4391_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2025.111501","volume":"142","author":"TA Rajasekera","year":"2025","unstructured":"Rajasekera TA, Joseph A, Pan H, Dreyfuss JM, Fida D, Wilson JC, et al. Sex differences in endocannabinoid and inflammatory markers associated with posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2025;142:111501.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4391_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-014-0265-0","volume":"14","author":"G Fischer","year":"2014","unstructured":"Fischer G, Ameis N, Parzer P, Plener PL, Groschwitz R, Vonderlin E, et al. The German version of the self-injurious thoughts and behaviors interview (SITBI-G): a tool to assess non-suicidal self-injury and suicidal behavior disorder. BMC Psychiatry. 2014;14:265.","journal-title":"BMC Psychiatry"},{"key":"4391_CR41","doi-asserted-by":"crossref","unstructured":"M\u00fcnster RD Wittchen, H-U, Zaudig, M & Fydrich, T (1997). SKID Strukturiertes Klinisches Interview f\u00fcr DSM-IV. Achse I und II. G\u00f6ttingen: Hogrefe, DM 158,-. Hiller, W., Zaudig, M. & Mombour, W. (1997). IDCL Internationale Diagnosen Checklisten f\u00fcr DSM-IV und ICD-10. G\u00f6ttingen: Hogrefe, DM 198,- bzw. DM 239,-. Z F\u00fcr Klin Psychol Psychother 1999; 28: 68\u201370.","DOI":"10.1026\/\/0084-5345.28.1.68"},{"key":"4391_CR42","volume-title":"Depressions-Inventar f\u00fcr Kinder und Jugendliche (DIKJ): Handweisung. 3. \u00fcberarbeitete und neu normierte Auflage","author":"J Stiensmeier-Pelster","year":"2014","unstructured":"Stiensmeier-Pelster J, Braune-Krickau M, Sch\u00fcrmann M, Duda K. Depressions-Inventar f\u00fcr Kinder und Jugendliche (DIKJ): Handweisung. 3. \u00fcberarbeitete und neu normierte Auflage. G\u00f6ttingen: Hogrefe; 2014."},{"key":"4391_CR43","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1024\/1422-4917\/a000115","volume":"39","author":"M Kaess","year":"2011","unstructured":"Kaess M, Parzer P, Mattern M, Resch F, Bifulco A, Brunner R. Validierung der deutschen version von fragebogen und korrespondierendem interview sowie ergebnisse einer untersuchung von zusammenhangen belastender kindheitserlebnisse mit suizidalen verhaltensweisen. Z Kinder Jugendpsychiatr Psychother. 2011;39:243\u201352.","journal-title":"Z Kinder Jugendpsychiatr Psychother"},{"key":"4391_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jmsacl.2023.02.002","volume":"28","author":"A Sens","year":"2023","unstructured":"Sens A, Rischke S, Hahnefeld L, Dorochow E, Sch\u00e4fer SMG, Thomas D, et al. Pre-analytical sample handling standardization for reliable measurement of metabolites and lipids in LC-MS-based clinical research. J Mass Spectrom Adv Clin Lab. 2023;28:35\u201346.","journal-title":"J Mass Spectrom Adv Clin Lab"},{"key":"4391_CR45","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.1021\/ac0624086","volume":"79","author":"J Williams","year":"2007","unstructured":"Williams J, Wood J, Pandarinathan L, Karanian DA, Bahr BA, Vouros P, et al. Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. Anal Chem. 2007;79:5582\u201393.","journal-title":"Anal Chem"},{"key":"4391_CR46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jchromb.2011.06.025","volume":"883\u2013884","author":"AA Zoerner","year":"2012","unstructured":"Zoerner AA, Batkai S, Suchy M-T, Gutzki F-M, Engeli S, Jordan J, et al. Simultaneous UPLC-MS\/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG\/1AG isomerization and degradation by toluene solvent extraction. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;883\u2013884:161\u201371.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"4391_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2020.122252","volume":"1152","author":"LJ Ney","year":"2020","unstructured":"Ney LJ, Felmingham KL, Bruno R, Matthews A, Nichols DS. Simultaneous quantification of endocannabinoids, oleoylethanolamide and steroid hormones in human plasma and saliva. J Chromatogr B Analyt Technol Biomed Life Sci. 2020;1152:122252.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"4391_CR48","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.psyneuen.2016.02.010","volume":"67","author":"S Wilker","year":"2016","unstructured":"Wilker S, Pfeiffer A, Elbert T, Ovuga E, Karabatsiakis A, Krumbholz A, et al. Endocannabinoid concentrations in hair are associated with PTSD symptom severity. Psychoneuroendocrinology. 2016;67:198\u2013206.","journal-title":"Psychoneuroendocrinology"},{"key":"4391_CR49","doi-asserted-by":"publisher","unstructured":"Lunge AR, Tansey RC, Elliot GO, Ferger MD, Mayo LM. Endocannabinoid system contributions to psychiatric risk. In: Marusak H, editor. Cannabis and the Developing Brain. Cham: Springer; 2025. pp. 353\u2013383. https:\/\/doi.org\/10.1007\/978-3-031-87990-6_15.","DOI":"10.1007\/978-3-031-87990-6_15"},{"key":"4391_CR50","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1055\/s-0038-1627520","volume":"36","author":"J Spohrs","year":"2017","unstructured":"Spohrs J, Rau V, Abler B. Rolle des endocannabinoidsystems f\u00fcr die therapie von angsterkrankungen. Nervenheilkunde. 2017;36:739\u201344.","journal-title":"Nervenheilkunde"},{"key":"4391_CR51","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1038\/s41386-020-0731-y","volume":"45","author":"NJ Kolla","year":"2020","unstructured":"Kolla NJ, Mizrahi R, Karas K, Wang C, Bagby RM, McMain S, et al. Elevated fatty acid amide hydrolase in the prefrontal cortex of borderline personality disorder: a 11CCURB positron emission tomography study. Neuropsychopharmacol. 2020;45:1834\u201341.","journal-title":"Neuropsychopharmacol"},{"key":"4391_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2025.110436","volume":"273","author":"MA De Pol","year":"2025","unstructured":"De Pol MA, Rafiei D, Meyer JH, Desmond KL, McMain S, Boileau I, et al. Fatty acid amide hydrolase in comorbid borderline personality disorder and major depressive disorder: Imaging with [11C]CURB PET. Neuropharmacology. 2025;273:110436.","journal-title":"Neuropharmacology"},{"key":"4391_CR53","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00406-013-0470-8","volume":"264","author":"C Schaefer","year":"2014","unstructured":"Schaefer C, Enning F, Mueller JK, Bumb JM, Rohleder C, Odorfer TM, et al. Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders. Eur Arch Psychiatry Clin Neurosci. 2014;264:459\u201363.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"4391_CR54","doi-asserted-by":"publisher","first-page":"17452","DOI":"10.3390\/ijms242417452","volume":"24","author":"J Spohrs","year":"2023","unstructured":"Spohrs J, K\u00fchnle V, Mikusky D, Sanh\u00fcter N, Macchia A, Nickel S, et al. Plasma endocannabinoid levels in patients with borderline personality disorder and healthy controls. Int J Mol Sci. 2023;24:17452.","journal-title":"Int J Mol Sci"},{"key":"4391_CR55","first-page":"366","volume":"21","author":"K Wingenfeld","year":"2018","unstructured":"Wingenfeld K, Dettenborn L, Kirschbaum C, Gao W, Otte C, Roepke S. Reduced levels of the endocannabinoid arachidonylethanolamide (AEA) in hair in patients with borderline personality disorder - a pilot study. Stress Amst Neth. 2018;21:366\u20139.","journal-title":"Stress Amst Neth"},{"key":"4391_CR56","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1089\/can.2021.0113","volume":"7","author":"S Desai","year":"2022","unstructured":"Desai S, Borg B, Cuttler C, Crombie KM, Rabinak CA, Hill MN, et al. A systematic review and meta-analysis on the effects of exercise on the endocannabinoid system. Cannabis Cannabinoid Res. 2022;7:388\u2013408.","journal-title":"Cannabis Cannabinoid Res"},{"key":"4391_CR57","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s13668-022-00436-x","volume":"11","author":"N Aguilera Vasquez","year":"2022","unstructured":"Aguilera Vasquez N, Nielsen DE. The endocannabinoid system and eating behaviours: a review of the current state of the evidence. Curr Nutr Rep. 2022;11:665\u201374. https:\/\/doi.org\/10.1007\/s13668-022-00436-x","journal-title":"Curr Nutr Rep"},{"key":"4391_CR58","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jmsacl.2021.11.001","volume":"22","author":"D Kratz","year":"2021","unstructured":"Kratz D, Thomas D, Gurke R. Endocannabinoids as potential biomarkers: it\u2019s all about pre-analytics. J Mass Spectrom Adv Clin Lab. 2021;22:56\u201363.","journal-title":"J Mass Spectrom Adv Clin Lab"},{"key":"4391_CR59","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1089\/can.2022.0174","volume":"9","author":"LA Chester","year":"2022","unstructured":"Chester LA, Englund A, Chesney E, Oliver D, Wilson J, Sovi S, et al. Effects of cannabidiol and delta-9-tetrahydrocannabinol on plasma endocannabinoid levels in healthy volunteers: a randomized double-blind four-arm crossover study. Cannabis Cannabinoid Res. 2022;9:188\u201398. https:\/\/doi.org\/10.1089\/can.2022.0174","journal-title":"Cannabis Cannabinoid Res"},{"key":"4391_CR60","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/s41386-025-02155-7","volume":"50","author":"HA Marusak","year":"2025","unstructured":"Marusak HA, Zundel CG, Shakir T, Ely SL, Carpenter C, Shampine M, et al. Circulating endocannabinoids in children and adolescents: associations with anxiety and the impact of selective serotonin reuptake inhibitors. Neuropsychopharmacology. 2025;50:1606\u201314. https:\/\/doi.org\/10.1038\/s41386-025-02155-7","journal-title":"Neuropsychopharmacology"},{"key":"4391_CR61","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.70006","volume":"66","author":"RC Tansey","year":"2025","unstructured":"Tansey RC, Ferger MD, Marusak HA, Mayo LM. Research review: what we have learned about the endocannabinoid system in developmental psychopathology. J Child Psychol Psychiatry. 2025;66:jcpp.70006.","journal-title":"J Child Psychol Psychiatry"},{"key":"4391_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/npp.2017.143","volume":"43","author":"HC Meyer","year":"2018","unstructured":"Meyer HC, Lee FS, Gee DG. The role of the endocannabinoid system and genetic variation in adolescent brain development. Neuropsychopharmacol. 2018;43:21\u201333.","journal-title":"Neuropsychopharmacol"},{"key":"4391_CR63","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/syn.20844","volume":"65","author":"L Heng","year":"2011","unstructured":"Heng L, Beverley JA, Steiner H, Tseng KY. Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic\/associative and sensorimotor cortical areas. Synapse. 2011;65:278\u201386.","journal-title":"Synapse"},{"key":"4391_CR64","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15947","volume":"12","author":"JJ Rosado\u2010Franco","year":"2024","unstructured":"Rosado\u2010Franco JJ, Ellison AL, White CJ, Price AS, Moore CF, Williams RE, et al. Roadmap for the expression of canonical and extended endocannabinoid system receptors and metabolic enzymes in peripheral organs of preclinical animal models. Physiol Rep. 2024;12:e15947.","journal-title":"Physiol Rep"},{"key":"4391_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59818-6","volume":"14","author":"L Bergunde","year":"2024","unstructured":"Bergunde L, Steudte-Schmiedgen S, Karl M, Jaramillo I, Gao W, Von Soest T, et al. Stability and inter-family associations of hair endocannabinoid and N-acylethanolamines across the perinatal period in mothers, fathers, and children. Sci Rep. 2024;14:9459.","journal-title":"Sci Rep"},{"key":"4391_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2026.111649","volume":"146","author":"L Bergunde","year":"2026","unstructured":"Bergunde L, Jaramillo I, Rihm L, Gao W, Weidner K, Von Soest T, et al. Associations between hair endocannabinoid concentrations and parental depressive symptoms: a longitudinal study of mothers, fathers, and their offspring up to two years postpartum. Prog Neuropsychopharmacol Biol Psychiatry. 2026;146:111649.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4391_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2022.110658","volume":"121","author":"A Walther","year":"2023","unstructured":"Walther A, Kirschbaum C, Wehrli S, Rothe N, Penz M, Wekenborg M, et al. Depressive symptoms are negatively associated with hair N-arachidonoylethanolamine (anandamide) levels: a cross-lagged panel analysis of four annual assessment waves examining hair endocannabinoids and cortisol. Prog Neuropsychopharmacol Biol Psychiatry. 2023;121:110658.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4391_CR68","doi-asserted-by":"publisher","DOI":"10.31234\/osf.io\/kajdv","volume":"15","author":"A Walther","year":"2024","unstructured":"Walther A, Eggenberger L, Debelak R, Kirschbaum C, H\u00e4berling I, Osuna E, et al. Major depressive disorder in children and adolescents is associated with reduced hair cortisol and anandamide (AEA): cross-sectional and longitudinal evidence from a large randomized clinical trial. Transl Psychiatry. 2024;15:183 https:\/\/doi.org\/10.31234\/osf.io\/kajdv","journal-title":"Transl Psychiatry"},{"key":"4391_CR69","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2215-0366(23)00193-1","volume":"10","author":"JJ McGrath","year":"2023","unstructured":"McGrath JJ, Al-Hamzawi A, Alonso J, Altwaijri Y, Andrade LH, Bromet EJ, et al. Age of onset and cumulative risk of mental disorders: a cross-national analysis of population surveys from 29 countries. Lancet Psychiatry. 2023;10:668\u201381.","journal-title":"Lancet Psychiatry"},{"key":"4391_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03519-9","volume":"15","author":"N Korem","year":"2025","unstructured":"Korem N, Bassir Nia A, Hillmer AT, D\u2019Souza D, Nabulsi N, Ropchan J, et al. Cannabinoid 1 receptor availability in posttraumatic stress disorder: a positron emission tomography study. Transl Psychiatry. 2025;15:310.","journal-title":"Transl Psychiatry"},{"key":"4391_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsycho.2023.108541","volume":"178","author":"S Valdivieso Barba","year":"2023","unstructured":"Valdivieso Barba S, Kirschbaum C, Gao W. Endocannabinoid and perceived stress: association analysis of endocannabinoid levels in hair versus levels in plasma and urine. Biol Psychol. 2023;178:108541.","journal-title":"Biol Psychol"},{"key":"4391_CR72","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00213-025-06831-w","volume":"243","author":"AM Jaster","year":"2025","unstructured":"Jaster AM, Ely SL, Zundel CG, Gowatch LC, Shampine M, Carpenter C, et al. Relationship between circulating plasma endocannabinoids in adolescents and maternal depressive symptoms. Psychopharmacology (Berl). 2025;243:369\u201381. https:\/\/doi.org\/10.1007\/s00213-025-06831-w","journal-title":"Psychopharmacology (Berl)"},{"key":"4391_CR73","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/j.pain.0000000000002268","volume":"162","author":"DP Finn","year":"2021","unstructured":"Finn DP, Haroutounian S, Hohmann AG, Krane E, Soliman N, Rice ASC. Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies. Pain. 2021;162:S5\u2013S25.","journal-title":"Pain"},{"key":"4391_CR74","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-3-662-46450-2_7","volume":"227","author":"SG Woodhams","year":"2015","unstructured":"Woodhams SG, Sagar DR, Burston JJ, Chapman V. The role of the endocannabinoid system in pain. Handb Exp Pharmacol. 2015;227:119\u201343.","journal-title":"Handb Exp Pharmacol"},{"key":"4391_CR75","doi-asserted-by":"crossref","unstructured":"Fatemi SA, Abssy SS, Bourke SL, Murray KB, Kyeremaa-Adjei C, Honigman L, et al. The contribution of baseline circulating endocannabinoids to individual differences in human pain sensitivity: a quantitative sensory testing study. Pain. 2026;167:854\u201365.","DOI":"10.1097\/j.pain.0000000000003850"},{"key":"4391_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2023.106406","volume":"158","author":"A Goreis","year":"2023","unstructured":"Goreis A, Prillinger K, Bedus C, Lipp R, Mayer A, Nater UM, et al. Physiological stress reactivity and self-harm: a meta-analysis. Psychoneuroendocrinology. 2023;158:106406.","journal-title":"Psychoneuroendocrinology"},{"key":"4391_CR77","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.psyneuen.2016.09.011","volume":"74","author":"C Reichl","year":"2016","unstructured":"Reichl C, Heyer A, Brunner R, Parzer P, V\u00f6lker JM, Resch F, et al. Hypothalamic-pituitary-adrenal axis, childhood adversity and adolescent nonsuicidal self-injury. Psychoneuroendocrinology. 2016;74:203\u201311.","journal-title":"Psychoneuroendocrinology"},{"key":"4391_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2019.104460","volume":"110","author":"C Reichl","year":"2019","unstructured":"Reichl C, Brunner R, Bender N, Parzer P, Koenig J, Resch F, et al. Adolescent nonsuicidal self-injury and cortisol response to the retrieval of adversity: a sibling study. Psychoneuroendocrinology. 2019;110:104460.","journal-title":"Psychoneuroendocrinology"},{"key":"4391_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.822046","volume":"10","author":"B Peng","year":"2022","unstructured":"Peng B, Li J, Liu H, Fang H, Zhao W, Chen G, et al. Childhood maltreatment, low serum cortisol levels, and non-suicidal self-injury in young adults with major depressive disorders. Front Pediatr. 2022;10:822046.","journal-title":"Front Pediatr"},{"key":"4391_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2024.107093","volume":"167","author":"C Reichl","year":"2024","unstructured":"Reichl C, Sch\u00e4r S, Lerch S, Hedinger N, Brunner R, Koenig J, et al. Two-year course of non-suicidal self-injury in an adolescent clinical cohort: the role of childhood adversity in interaction with cortisol secretion. Psychoneuroendocrinology. 2024;167:107093.","journal-title":"Psychoneuroendocrinology"},{"key":"4391_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03742-4","volume":"15","author":"K Petrowski","year":"2025","unstructured":"Petrowski K, Bindila L, Herhaus B, Gao W, Conrad R. Stress-Buffer-Hypothesis: blood endocannabinoids in healthy males under standardized psychosocial stress induction and resting condition. Transl Psychiatry. 2025;15:517.","journal-title":"Transl Psychiatry"},{"key":"4391_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsycho.2022.108281","volume":"169","author":"J Spohrs","year":"2022","unstructured":"Spohrs J, Prost M, Ulrich M, Plener PL, Bindila L, Abler B. Endocannabinoid system reactivity during stress processing in healthy humans. Biol Psychol. 2022;169:108281.","journal-title":"Biol Psychol"},{"key":"4391_CR83","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejphar.2018.07.039","volume":"834","author":"V Micale","year":"2018","unstructured":"Micale V, Drago F. Endocannabinoid system, stress and HPA axis. Eur J Pharmacol. 2018;834:230\u20139.","journal-title":"Eur J Pharmacol"},{"key":"4391_CR84","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.biopsych.2019.07.034","volume":"87","author":"LM Mayo","year":"2019","unstructured":"Mayo LM, Asratian A, Lind\u00e9 J, Morena M, Haataja R, Hammar V, et al. Elevated anandamide, enhanced recall of fear extinction, and attenuated stress responses following inhibition of fatty acid amide hydrolase: a randomized, controlled experimental medicine trial. Biol Psychiatry. 2019;87:538\u201347.","journal-title":"Biol Psychiatry"},{"key":"4391_CR85","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s41380-018-0215-1","volume":"25","author":"LM Mayo","year":"2020","unstructured":"Mayo LM, Asratian A, Lind\u00e9 J, Holm L, N\u00e4tt D, Augier G, et al. Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and mice. Mol Psychiatry. 2020;25:993\u20131005.","journal-title":"Mol Psychiatry"},{"key":"4391_CR86","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.psyneuen.2013.08.004","volume":"38","author":"MN Hill","year":"2013","unstructured":"Hill MN, Bierer LM, Makotkine I, Golier JA, Galea S, McEwen BS, et al. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. Psychoneuroendocrinology. 2013;38:2952\u201361.","journal-title":"Psychoneuroendocrinology"},{"key":"4391_CR87","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/s41386-025-02128-w","volume":"50","author":"LM Mayo","year":"2025","unstructured":"Mayo LM, Gauffin E, Petrie GN, Tansey R, Mazurka R, Haggarty CJ, et al. The efficacy of elevating anandamide via inhibition of fatty acid amide hydrolase (FAAH) combined with internet-delivered cognitive behavioral therapy in the treatment of post-traumatic stress disorder: a randomized, placebo-controlled clinical trial. Neuropsychopharmacology. 2025;50:1564\u201372. https:\/\/doi.org\/10.1038\/s41386-025-02128-w","journal-title":"Neuropsychopharmacology"},{"key":"4391_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-026-03864-3","volume":"16","author":"R Tansey","year":"2026","unstructured":"Tansey R, Perini I, Petrie GN, Haggarty CJ, Mazurka R, Yngve A, et al. Functional neuroimaging of fatty acid amide hydrolase inhibition in posttraumatic stress disorder: a randomized clinical trial. Transl Psychiatry. 2026;16:95.","journal-title":"Transl Psychiatry"},{"key":"4391_CR89","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00787-020-01533-4","volume":"30","author":"D Daukantait\u0117","year":"2021","unstructured":"Daukantait\u0117 D, Lundh L-G, W\u00e5ngby-Lundh M, Clar\u00e9us B, Bj\u00e4rehed J, Zhou Y, et al. What happens to young adults who have engaged in self-injurious behavior as adolescents? A 10-year follow-up. Eur Child Adolesc Psychiatry. 2021;30:475\u201392.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"4391_CR90","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1038\/s41380-023-02033-y","volume":"28","author":"I Perini","year":"2023","unstructured":"Perini I, Mayo LM, Capusan AJ, Paul ER, Yngve A, Kampe R, et al. Resilience to substance use disorder following childhood maltreatment: association with peripheral biomarkers of endocannabinoid function and neural indices of emotion regulation. Mol Psychiatry. 2023;28:2563\u201371. https:\/\/doi.org\/10.1038\/s41380-023-02033-y","journal-title":"Mol Psychiatry"},{"key":"4391_CR91","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00213-025-06843-6","volume":"243","author":"GN Petrie","year":"2025","unstructured":"Petrie GN, Mazurka R, Paul ER, Stensson N, Ghafouri B, Hill MN, et al. Effects of acute alcohol administration on endocannabinoids and relation to subjective effects. Psychopharmacology (Berl). 2025;243:401\u201311. https:\/\/doi.org\/10.1007\/s00213-025-06843-6","journal-title":"Psychopharmacology (Berl)"},{"key":"4391_CR92","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/00952990.2025.2456499","volume":"51","author":"GO Elliott","year":"2025","unstructured":"Elliott GO, Petrie GN, Kroll SL, Roche DJO, Mayo LM. Changes in peripheral endocannabinoid levels in substance use disorders: a review of clinical evidence. Am J Drug Alcohol Abuse. 2025;51:152\u201364.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"4391_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01808-1","volume":"12","author":"TA deRoon-Cassini","year":"2022","unstructured":"deRoon-Cassini TA, Bergner CL, Chesney SA, Schumann NR, Lee TS, Brasel KJ, et al. Circulating endocannabinoids and genetic polymorphisms as predictors of posttraumatic stress disorder symptom severity: heterogeneity in a community-based cohort. Transl Psychiatry. 2022;12:48.","journal-title":"Transl Psychiatry"},{"key":"4391_CR94","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41386-024-01881-8","volume":"49","author":"SL Kroll","year":"2024","unstructured":"Kroll SL, Meier P, Mayo LM, Gertsch J, Quednow BB. Endocannabinoids and related lipids linked to social exclusion in individuals with chronic non-medical prescription opioid use. Neuropsychopharmacology. 2024;49:1630\u20139. https:\/\/doi.org\/10.1038\/s41386-024-01881-8","journal-title":"Neuropsychopharmacology"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04391-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04391-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04391-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:02:07Z","timestamp":1788454927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04391-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4391"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04391-x","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Marc D. Ferger has received financial support from Boehringer Ingelheim for activities unrelated to this study. He also served as a scientific advisor for Synendos Therapeutics.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The Ethics Committee of the Faculty of Medicine, University of Heidelberg, approved the scientific evaluation of AtR!Sk (IRB approval number S-449\/2013) and the additional neurobiological assessments (IRB approval number S-514\/2015). All participants and their caregivers provided written informed consent. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics declaration","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"450"}}